Építés alatt – nem éles oldal
Belépés
Fut, nem toborozFázis nélkül

Single-Cell Sequence Technology Used to Reveal Heterogeneity of Secondary Hyperparathyroidism

A legfontosabb adatok

Ki végzi
China-Japan Friendship Hospital
Hol
Kína1 helyszín, 1 országbanVálassz országot a helyszínekhez
Azonosító
Állapot
Fut, nem toboroz
Résztvevők
12 fő, tervezett
Kezdés
2023. nov. 10.
Befejezés
2025. júl. 31.
A vizsgálat típusa
Megfigyeléses, 3 csoport
A vizsgált kezelések
  • Single-cell sequencing
A regiszteradat frissítve
2024. december 27.

Ki vehet részt

Életkor
18 év – 80 év
Nem
Nők és férfiak
Egészséges önkéntesek
Nem vehetnek részt

A regiszter feltételei, szó szerint

Mind a 6 feltétel megnézéseKevesebb

Ki vehet részt

  • Study participants with a diagnosis of secondary hyperparathyroidism who underwent surgical treatment
  • Study participants with a diagnosis of primary hyperparathyroidism who underwent surgical treatment
  • Study participants who have obtained informed consent

Ki nem vehet részt

  • Other non-secondary hyperparathyroidism conditions such as primary hyperparathyroidism were excluded at the time of inclusion of study participants with essential hyperparathyroidism
  • Other non-primary hyperparathyroid conditions such as secondary hyperparathyroidism were excluded at the time of inclusion of study participants with essential hyperparathyroidism
  • Refusal of informed consent

Hol van ez a vizsgálat?

Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.

A vizsgálatról

Mit akar kideríteni a vizsgálat

This project intends to select cases that meet the research requirements, take secondary hyperparathyroidism, primary hyperparathyroidism and normal human parathyroid tissue, a total of three groups, 4 cases in each group, through the method of single-cell transcription and sequencing, construct a map of human parathyroid function types, reveal the gene structure and gene expression status of cells, and visualize the expression characteristics, intercellular heterogeneity, and heterogeneity of cell subsets of secondary hyperparathyroid cells in a hierarchical manner, draw a single-cell map, and compare the differences between groups. To explore the pathogenesis of secondary hyperparathyroidism.

A teljes eredeti leírásKevesebb

Secondary hyperparathyroidism, parathyroid tissue of primary hyperparathyroidism and normal parathyroid tissue obtained by accident were collected, frozen and preserved, frozen tissue thawed, single-cell suspension was prepared and each cell was specifically labeled by the Mozhuo Genomics system, after oil breaking, polymerase chain reaction amplification, reverse transcription to obtain complementary DNA, and a library of complementary DNA that passed quality inspection was constructed to obtain high-quality data of parathyroid cells. Cell Ranger, R Seurat package, and t-SNE dimensionality reduction diagram were used to reduce the dimensionality, cluster, and visualize the data.

In order to construct a single-cell atlas of parathyroid glands, investigators performed cluster analysis of similar cells according to the gene expression profile, and then visualized the data by t-SNE. According to the results of cell clustering, the specific and highly expressed genes in each cell cluster were identified. Cell populations were identified according to the expression of landmark genes, and the differences in cell types and proportions between groups were compared.

A vizsgálat 3 csoportja

  • Secondary Hyperparathyroidism

    Patients who were diagnosed as secondary hyperparathyroidism

    Kezelés: Single-cell sequencing

  • Primary Hyperparathyroidism

    Patients who were diagnosed as primary hyperparathyroidism

    Kezelés: Single-cell sequencing

  • Normal group

    Parathyroid tissue obtained incidentally during other neck surgeries, derived from people without parathyroid disease.

    Kezelés: Single-cell sequencing

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
A regiszteradat frissítve
2024. december 27.